Filing Details
- Accession Number:
- 0001209191-20-050590
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-15 19:22:28
- Reporting Period:
- 2020-09-11
- Accepted Time:
- 2020-09-15 19:22:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1422143 | Kura Oncology Inc. | KURA | Pharmaceutical Preparations (2834) | 611547851 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1589597 | Edward Troy Wilson | C/O Kura Oncology, Inc. 12730 High Bluff Drive, Suite 400 San Diego CA 92130 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-09-11 | 17,926 | $6.15 | 46,022 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-09-11 | 17,926 | $28.00 | 28,096 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-11 | 485 | $28.00 | 305,226 | No | 4 | S | Indirect | by Araxes Pharma LLC |
| Common Stock | Disposition | 2020-09-14 | 98,490 | $28.82 | 206,736 | No | 4 | S | Indirect | by Araxes Pharma LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | by Araxes Pharma LLC |
| No | 4 | S | Indirect | by Araxes Pharma LLC |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to purchase common stock | Disposition | 2020-09-11 | 17,926 | $0.00 | 17,926 | $6.15 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 157,021 | 2027-01-22 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,795,017 | Indirect | by Red Fish Blue Fish Revocable Trust |
Footnotes
- The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020.
- The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2019 and amended on June 8, 2020.
- This transaction was executed in multiple trades at prices ranging from $28.00 to $29.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This option vests in 48 equal monthly installments commencing on January 23, 2017.
Billionaire Hedge Funds
